Global Irritable Bowel Syndrome (IBS) Market by Manufacturers, Countries, Type and Application, Forecast to 2022

December 2017 | 118 pages | ID: GB12833C511EN
GlobalInfoResearch

Abstracts

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

Scope of the Report:

This report focuses on the Irritable Bowel Syndrome (IBS) in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

• Allergan
• Valeant Pharmaceuticals
• Takeda
• Sucampo Pharmaceuticals
• McNeil Consumer Healthcare
• Sebela Pharmaceuticals
• Astellas Pharmaceuticals
• IM HealthScience

Market Segment by Regions, regional analysis covers

• North America (USA, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Columbia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• IBS-D Drug
• IBS-C Drug
• Other

Market Segment by Applications, can be divided into

• Women
• Men

There are 15 Chapters to deeply display the global Irritable Bowel Syndrome (IBS) market.

Chapter 1, to describe Irritable Bowel Syndrome (IBS) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Irritable Bowel Syndrome (IBS), with sales, revenue, and price of Irritable Bowel Syndrome (IBS), in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Irritable Bowel Syndrome (IBS), for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Irritable Bowel Syndrome (IBS) market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Irritable Bowel Syndrome (IBS) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Irritable Bowel Syndrome (IBS) Introduction
1.2 Market Analysis by Type
  1.2.1 IBS-D Drug
  1.2.2 IBS-C Drug
  1.2.3 Other
1.3 Market Analysis by Applications
  1.3.1 Women
  1.3.2 Men
1.4 Market Analysis by Regions
  1.4.1 North America (USA, Canada and Mexico)
    1.4.1.1 USA Market States and Outlook (2012-2022)
    1.4.1.2 Canada Market States and Outlook (2012-2022)
    1.4.1.3 Mexico Market States and Outlook (2012-2022)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2012-2022)
    1.4.2.2 France Market States and Outlook (2012-2022)
    1.4.2.3 UK Market States and Outlook (2012-2022)
    1.4.2.4 Russia Market States and Outlook (2012-2022)
    1.4.2.5 Italy Market States and Outlook (2012-2022)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2012-2022)
    1.4.3.2 Japan Market States and Outlook (2012-2022)
    1.4.3.3 Korea Market States and Outlook (2012-2022)
    1.4.3.4 India Market States and Outlook (2012-2022)
    1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2012-2022)
    1.4.4.2 Egypt Market States and Outlook (2012-2022)
    1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
    1.4.4.4 South Africa Market States and Outlook (2012-2022)
    1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Allergan
  2.1.1 Business Overview
  2.1.2 Irritable Bowel Syndrome (IBS) Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Allergan Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Valeant Pharmaceuticals
  2.2.1 Business Overview
  2.2.2 Irritable Bowel Syndrome (IBS) Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Takeda
  2.3.1 Business Overview
  2.3.2 Irritable Bowel Syndrome (IBS) Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Takeda Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sucampo Pharmaceuticals
  2.4.1 Business Overview
  2.4.2 Irritable Bowel Syndrome (IBS) Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 McNeil Consumer Healthcare
  2.5.1 Business Overview
  2.5.2 Irritable Bowel Syndrome (IBS) Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sebela Pharmaceuticals
  2.6.1 Business Overview
  2.6.2 Irritable Bowel Syndrome (IBS) Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Astellas Pharmaceuticals
  2.7.1 Business Overview
  2.7.2 Irritable Bowel Syndrome (IBS) Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 IM HealthScience
  2.8.1 Business Overview
  2.8.2 Irritable Bowel Syndrome (IBS) Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) MARKET COMPETITION, BY MANUFACTURER

3.1 Global Irritable Bowel Syndrome (IBS) Sales and Market Share by Manufacturer
3.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
  3.3.1 Top 3 Irritable Bowel Syndrome (IBS) Manufacturer Market Share
  3.3.2 Top 6 Irritable Bowel Syndrome (IBS) Manufacturer Market Share
3.4 Market Competition Trend

4 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) MARKET ANALYSIS BY REGIONS

4.1 Global Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Regions
  4.1.1 Global Irritable Bowel Syndrome (IBS) Sales by Regions (2012-2017)
  4.1.2 Global Irritable Bowel Syndrome (IBS) Revenue by Regions (2012-2017)
4.2 North America Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
4.3 Europe Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
4.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
4.5 South America Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
4.6 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)

5 NORTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) BY COUNTRIES

5.1 North America Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Countries
  5.1.1 North America Irritable Bowel Syndrome (IBS) Sales by Countries (2012-2017)
  5.1.2 North America Irritable Bowel Syndrome (IBS) Revenue by Countries (2012-2017)
5.2 USA Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
5.3 Canada Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
5.4 Mexico Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)

6 EUROPE IRRITABLE BOWEL SYNDROME (IBS) BY COUNTRIES

6.1 Europe Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Countries
  6.1.1 Europe Irritable Bowel Syndrome (IBS) Sales by Countries (2012-2017)
  6.1.2 Europe Irritable Bowel Syndrome (IBS) Revenue by Countries (2012-2017)
6.2 Germany Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
6.3 UK Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
6.4 France Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
6.5 Russia Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
6.6 Italy Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)

7 ASIA-PACIFIC IRRITABLE BOWEL SYNDROME (IBS) BY COUNTRIES

7.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales by Countries (2012-2017)
  7.1.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue by Countries (2012-2017)
7.2 China Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
7.3 Japan Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
7.4 Korea Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
7.5 India Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
7.6 Southeast Asia Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)

8 SOUTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) BY COUNTRIES

8.1 South America Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Countries
  8.1.1 South America Irritable Bowel Syndrome (IBS) Sales by Countries (2012-2017)
  8.1.2 South America Irritable Bowel Syndrome (IBS) Revenue by Countries (2012-2017)
8.2 Brazil Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
8.3 Argentina Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
8.4 Columbia Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)

9 MIDDLE EAST AND AFRICA IRRITABLE BOWEL SYNDROME (IBS) BY COUNTRIES

9.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Countries (2012-2017)
  9.1.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Countries (2012-2017)
9.2 Saudi Arabia Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
9.3 UAE Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
9.4 Egypt Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
9.5 Nigeria Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
9.6 South Africa Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)

10 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) MARKET SEGMENT BY TYPE

10.1 Global Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Type (2012-2017)
  10.1.1 Global Irritable Bowel Syndrome (IBS) Sales and Market Share by Type (2012-2017)
  10.1.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Type (2012-2017)
10.2 IBS-D Drug Sales Growth and Price
  10.2.1 Global IBS-D Drug Sales Growth (2012-2017)
  10.2.2 Global IBS-D Drug Price (2012-2017)
10.3 IBS-C Drug Sales Growth and Price
  10.3.1 Global IBS-C Drug Sales Growth (2012-2017)
  10.3.2 Global IBS-C Drug Price (2012-2017)
10.4 Other Sales Growth and Price
  10.4.1 Global Other Sales Growth (2012-2017)
  10.4.2 Global Other Price (2012-2017)

11 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) MARKET SEGMENT BY APPLICATION

11.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2012-2017)
11.2 Women Sales Growth (2012-2017)
11.3 Men Sales Growth (2012-2017)

12 IRRITABLE BOWEL SYNDROME (IBS) MARKET FORECAST (2017-2022)

12.1 Global Irritable Bowel Syndrome (IBS) Sales, Revenue and Growth Rate (2017-2022)
12.2 Irritable Bowel Syndrome (IBS) Market Forecast by Regions (2017-2022)
  12.2.1 North America Irritable Bowel Syndrome (IBS) Market Forecast (2017-2022)
  12.2.2 Europe Irritable Bowel Syndrome (IBS) Market Forecast (2017-2022)
  12.2.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Forecast (2017-2022)
  12.2.4 South America Irritable Bowel Syndrome (IBS) Market Forecast (2017-2022)
  12.2.5 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Forecast (2017-2022)
12.3 Irritable Bowel Syndrome (IBS) Market Forecast by Type (2017-2022)
12.4 Irritable Bowel Syndrome (IBS) Market Forecast by Application (2017-2022)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES


Figure Irritable Bowel Syndrome (IBS) Picture
Table Product Specifications of Irritable Bowel Syndrome (IBS)
Figure Global Sales Market Share of Irritable Bowel Syndrome (IBS) by Types in 2016
Table Irritable Bowel Syndrome (IBS) Types for Major Manufacturers
Figure IBS-D Drug Picture
Figure IBS-C Drug Picture
Figure Other Picture
Table Irritable Bowel Syndrome (IBS) Sales Market Share by Applications in 2016
Figure Women Picture
Figure Men Picture
Figure USA Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2012-2022)
Figure Canada Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2012-2022)
Figure Mexico Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2012-2022)
Figure Germany Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2012-2022)
Figure France Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2012-2022)
Figure UK Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2012-2022)
Figure China Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2012-2022)
Figure Japan Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2012-2022)
Figure Korea Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2012-2022)
Figure India Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2012-2022)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2012-2022)
Figure Brazil Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2012-2022)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Irritable Bowel Syndrome (IBS) Type and Applications
Table Allergan Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Valeant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Type and Applications
Table Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Irritable Bowel Syndrome (IBS) Type and Applications
Table Takeda Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sucampo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Type and Applications
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table McNeil Consumer Healthcare Basic Information, Manufacturing Base and Competitors
Table McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Type and Applications
Table McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sebela Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Type and Applications
Table Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Type and Applications
Table Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table IM HealthScience Basic Information, Manufacturing Base and Competitors
Table IM HealthScience Irritable Bowel Syndrome (IBS) Type and Applications
Table IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Irritable Bowel Syndrome (IBS) Sales by Manufacturer (2016-2017)
Figure Global Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturer in 2016
Figure Global Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturer in 2017
Table Global Irritable Bowel Syndrome (IBS) Revenue by Manufacturer (2016-2017)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturer in 2016
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturer in 2017
Figure Global Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure Global Irritable Bowel Syndrome (IBS) Revenue and Growth (2012-2017)
Table Global Irritable Bowel Syndrome (IBS) Sales by Regions (2012-2017)
Table Global Irritable Bowel Syndrome (IBS) Sales Market Share by Regions (2012-2017)
Table Global Irritable Bowel Syndrome (IBS) Revenue by Regions (2012-2017)
Table Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Regions in 2012
Table Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Regions in 2016
Figure North America Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure Europe Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure South America Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure North America Irritable Bowel Syndrome (IBS) Revenue and Growth (2012-2017)
Table North America Irritable Bowel Syndrome (IBS) Sales by Countries (2012-2017)
Table North America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2012-2017)
Figure North America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries in 2012
Figure North America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries in 2016
Table North America Irritable Bowel Syndrome (IBS) Revenue by Countries (2012-2017)
Table North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2012-2017)
Figure North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2012
Figure North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2016
Figure USA Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure Canada Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure Mexico Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure Europe Irritable Bowel Syndrome (IBS) Revenue and Growth (2012-2017)
Table Europe Irritable Bowel Syndrome (IBS) Sales by Countries (2012-2017)
Table Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2012-2017)
Table Europe Irritable Bowel Syndrome (IBS) Revenue by Countries (2012-2017)
Table Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2012
Table Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2016
Figure Germany Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure UK Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure France Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure Russia Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure Italy Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue and Growth (2012-2017)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Sales by Countries (2012-2017)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue by Countries (2012-2017)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2012-2017)
Figure China Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure Japan Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure Korea Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure India Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure South America Irritable Bowel Syndrome (IBS) Revenue and Growth (2012-2017)
Table South America Irritable Bowel Syndrome (IBS) Sales by Countries (2012-2017)
Table South America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2012-2017)
Figure South America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries in 2016
Table South America Irritable Bowel Syndrome (IBS) Revenue by Countries (2012-2017)
Table South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2012-2017)
Figure South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2012
Figure South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2016
Figure Brazil Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure Argentina Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure Columbia Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue and Growth (2012-2017)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Countries (2012-2017)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2012-2017)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Countries in 2016
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Countries (2012-2017)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2012-2017)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2012
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2016
Figure Saudi Arabia Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure UAE Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure Egypt Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure Nigeria Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Figure South Africa Irritable Bowel Syndrome (IBS) Sales and Growth (2012-2017)
Table Global Irritable Bowel Syndrome (IBS) Sales by Type (2012-2017)
Table Global Irritable Bowel Syndrome (IBS) Sales Share by Type (2012-2017)
Table Global Irritable Bowel Syndrome (IBS) Revenue by Type (2012-2017)
Table Global Irritable Bowel Syndrome (IBS) Revenue Share by Type (2012-2017)
Figure Global IBS-D Drug Sales Growth (2012-2017)
Figure Global IBS-D Drug Price (2012-2017)
Figure Global IBS-C Drug Sales Growth (2012-2017)
Figure Global IBS-C Drug Price (2012-2017)
Figure Global Other Sales Growth (2012-2017)
Figure Global Other Price (2012-2017)
Table Global Irritable Bowel Syndrome (IBS) Sales by Application (2012-2017)
Table Global Irritable Bowel Syndrome (IBS) Sales Share by Application (2012-2017)
Figure Global Women Sales Growth (2012-2017)
Figure Global Men Sales Growth (2012-2017)
Figure Global Irritable Bowel Syndrome (IBS) Sales, Revenue and Growth Rate (2017 -2022)
Table Global Irritable Bowel Syndrome (IBS) Sales Forecast by Regions (2017-2022)
Table Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Regions (2017-2022)
Figure North America Sales Irritable Bowel Syndrome (IBS) Market Forecast (2017-2022)
Figure Europe Sales Irritable Bowel Syndrome (IBS) Market Forecast (2017-2022)
Figure Asia-Pacific Sales Irritable Bowel Syndrome (IBS) Market Forecast (2017-2022)
Figure South America Sales Irritable Bowel Syndrome (IBS) Market Forecast (2017-2022)
Figure Middle East and Africa Sales Irritable Bowel Syndrome (IBS) Market Forecast (2017-2022)
Table Global Irritable Bowel Syndrome (IBS) Sales Forecast by Type (2017-2022)
Table Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Type (2017-2022)
Table Global Irritable Bowel Syndrome (IBS) Sales Forecast by Application (2017-2022)
Table Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List